124 related articles for article (PubMed ID: 21240369)
1. Effects of short-term exposure to haloperidol and reserpine on dopamine turnover in nigrostriatal system in rat brain.
Dovedova EL; Voronkov DN; Khudoerkov RM
Bull Exp Biol Med; 2010 Dec; 150(2):188-90. PubMed ID: 21240369
[TBL] [Abstract][Full Text] [Related]
2. [Changes in neuroglial interactions in the cerebral nigrostriatal structures in a model of dopamine system dysfunction].
Voronkov DN; Khudoerkov RM; Dovedova EL
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(7):47-51. PubMed ID: 23994921
[TBL] [Abstract][Full Text] [Related]
3. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
4. Action of beta-phenylethylamine and related amines on nigrostriatal dopamine neurotransmission.
Barroso N; Rodriguez M
Eur J Pharmacol; 1996 Feb; 297(3):195-203. PubMed ID: 8666050
[TBL] [Abstract][Full Text] [Related]
5. Poor evidence for depolarization block but uncoupling of nigral from striatal dopamine metabolism after chronic haloperidol treatment in the rat.
Chrapusta SJ; Egan MF
J Neural Transm (Vienna); 2006 May; 113(5):573-82. PubMed ID: 16082510
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neurochemical effects induced by reserpine in mice.
de Freitas CM; Busanello A; Schaffer LF; Peroza LR; Krum BN; Leal CQ; Ceretta AP; da Rocha JB; Fachinetto R
Psychopharmacology (Berl); 2016 Feb; 233(3):457-67. PubMed ID: 26514557
[TBL] [Abstract][Full Text] [Related]
7. Dopaminergic neurons in explants of substantia nigra in culture.
Coyle JT; Jacobowitz D; Klein D; Axelrod J
J Neurobiol; 1973; 4(5):461-70. PubMed ID: 4147763
[No Abstract] [Full Text] [Related]
8. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
9. Chronic selegiline administration transiently decreases tyrosine hydroxylase activity and mRNA in the rat nigrostriatal pathway.
Vrana SL; Azzaro AJ; Vrana KE
Mol Pharmacol; 1992 May; 41(5):839-44. PubMed ID: 1350320
[TBL] [Abstract][Full Text] [Related]
10. Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity.
McMillen BA; Shore PA
Naunyn Schmiedebergs Arch Pharmacol; 1980 Aug; 313(1):39-44. PubMed ID: 6111026
[TBL] [Abstract][Full Text] [Related]
11. High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats.
Meissner W; Harnack D; Reese R; Paul G; Reum T; Ansorge M; Kusserow H; Winter C; Morgenstern R; Kupsch A
J Neurochem; 2003 May; 85(3):601-9. PubMed ID: 12694386
[TBL] [Abstract][Full Text] [Related]
12. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
Arbilla S; Langer SZ
Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
[No Abstract] [Full Text] [Related]
13. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons.
Melamed E; Durst R; Frucht Y; Globus M
Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163
[TBL] [Abstract][Full Text] [Related]
14. Effects of haloperidol and melatonin on the in situ activity of nigrostriatal tyrosine hydroxylase in male Syrian hamsters.
Vriend J; Dreger L
Life Sci; 2006 Mar; 78(15):1707-12. PubMed ID: 16263138
[TBL] [Abstract][Full Text] [Related]
15. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
Heeringa MJ; Abercrombie ED
J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
[TBL] [Abstract][Full Text] [Related]
16. Reserpine-insensitive dopamine release in the substantia nigra?
Elverfors A; Nissbrandt H
Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
[TBL] [Abstract][Full Text] [Related]
17. Nigrostriatal dopamine neurons: modulation of impulse-induced activation of tyrosine hydroxylation by dopamine autoreceptors.
Murrin LC; Roth RH
Neuropharmacology; 1987 Jun; 26(6):591-5. PubMed ID: 2885775
[TBL] [Abstract][Full Text] [Related]
18. (-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release.
Shimazu S; Takahata K; Katsuki H; Tsunekawa H; Tanigawa A; Yoneda F; Knoll J; Akaike A
Eur J Pharmacol; 2001 Jun; 421(3):181-9. PubMed ID: 11516435
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
20. Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: effects of acute haloperidol and related compounds.
Salvatore MF; Garcia-Espana A; Goldstein M; Deutch AY; Haycock JW
J Neurochem; 2000 Jul; 75(1):225-32. PubMed ID: 10854265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
